|
1. |
The possible role of iron in the etiopathology of parkinson's disease |
|
Movement Disorders,
Volume 8,
Issue 1,
1993,
Page 1-12
M. B. H. Youdim,
D. Ben‐Shachar,
P. Riederer,
Preview
|
PDF (1249KB)
|
|
摘要:
AbstractThe identification of 6‐ hydroxydopamine (6‐ OHDA) andN‐ methyl‐ 4‐ phenyl‐ 1, 2, 3, 6‐ tetrahydropyridine (MPTP) as dopaminergic neurotoxins that can induce parkinsonism in humans and animals has contributed to a better understanding of Parkinson's disease (PD). Although the involvement of similar neurotoxins has been implicated in PD, the etiology of the disease remains obscure. However, the recently described pathology of PD supports the view for a state of oxidative stress in the substantia nigra (SN), resulting as a consequence of the selective accumulation of iron in SN zone compacta and within the melanized dopamine neurons. Whether iron is directly involved cannot be ascertained. Nevertheless, the biochemical changes due to oxidative stress resulting from tisue iron overload (siderosis) are similar to those now being identified in parkinsonian SN. These include the reduction of mitochondrial electron transport, complex I and III activities, glutathione peroxidase activity, glutathione (GSH) ascorbate, calcium‐ binding protein, and superoxide dismutase and increase of basal lipid peroxidation and deposition of iron. The participation of iron‐ induced oxygen free radicals in the process of nigrostriatal dopamine neuron degeneration is strengthened by recent studies in which the neurotoxicity of 6‐ OHDA has been linked to the release of iron from its binding sites in ferritin. This is further supported by experiments with the prototypeiron chelator, desferrioxamine (Desferal), a free‐ radical inhibitor, which protects against 6‐ OHDA‐ induced lesions in the rat. Indeed, intranigral iron injection in rats produces a selective lesioning of dopamine neurons, resulting in a behavioral and
ISSN:0885-3185
DOI:10.1002/mds.870080102
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
2. |
Reaction time responses in parkinsonian and hemiparkinsonian patients |
|
Movement Disorders,
Volume 8,
Issue 1,
1993,
Page 13-18
A. Mazzucchi,
E. Sinforiani,
L. Ludovico,
M. Turla,
C. Pacchetti,
R. Brianti,
M. Parma,
G. Nappi,
Preview
|
PDF (552KB)
|
|
摘要:
AbstractTwenty‐ one normal subjects, 32 bilateral parkinsonian patients (BPs) and 29 hemiparkinsonian patients (HP) were submitted to separate or sequentially associated motor tasks that included simple reaction times (RT), choice RTs, directional RTs, and movement RTs. The results showed that simple RTs, directional RTs, and movement times (MT) were slower in BPs as compared to normal subjects; for choice RTs there was no difference. Response patterns were similar in normal controls and BPs. In both groups RTs became more prolonged as sequentially programmed operations increased. If movement occurred at the end of the sequence, they prolonged the RTs of the preceding operations, but MTs per se did not vary. In HPs the same results were observed on the “bad” hand side versus normal controls and versus the healthy side, but a significant statistical level was reached mainly when the “bad” hand was the
ISSN:0885-3185
DOI:10.1002/mds.870080103
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
3. |
Phenytoin and dyskinesias: A report of two cases and review of the literature |
|
Movement Disorders,
Volume 8,
Issue 1,
1993,
Page 19-27
M. B. Harrison,
G. R. Lyons,
E. R. Landow,
Preview
|
PDF (1174KB)
|
|
摘要:
AbstractDyskinesia is a recognized but uncommon side‐ effect of treatment with phenytoin. Two additional cases of dyskinesia during treatment with phenytoin are described; both had radiographically documented thalamic infarctions. The reported experience to date with movement disorders induced by phenytoin is reviewed and the clinical features summarized. The available experimental evidence addressing the mechanism underlying this side effect is discusse
ISSN:0885-3185
DOI:10.1002/mds.870080104
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
4. |
The cholinergic system‐dependent myoclonus of the baboon papio is a reticular reflex myoclonus |
|
Movement Disorders,
Volume 8,
Issue 1,
1993,
Page 28-32
I. Rektor,
M. Švejdová,
C. Silva‐Barrat,
C. Menini,
Preview
|
PDF (426KB)
|
|
摘要:
AbstractNeurophysiological studies were performed on four Papio papio baboons presenting with nonepileptic myoclonus (a startle response resembling stimulus‐sensitive jerk). Investigations of the EEG, back‐averaged EEG, and somatosensory evoked potentials revealed the absence of cortical correlates preceeding the jerks, and exclusion of cerebral cortex involvement. No long‐latency reflexes could be recorded in these animals. The jerks were symmetric when evoked by unilateral stimulation in normal baboons as well as in a split‐brain animal. Polymyographic records showed that the first muscle involved during the jerk was the trapezius; other muscles were involved with latencies increasing in both cranial and caudal directions. From these data, nonepileptic myoclonus of baboons can be classified as a reticular reflex myoclonus. The involvement of cranial nerves did not follow the layout of the nuclei in the brainstem, indicating that the jerk is most likely generated as a complete movement. The generating structure is probably under cholinergic control. Finally, the Papio papio baboon, which was already known as a model for cortical myoclonus elicited by intermittent photic stimulation in predisposed animals, can also be considered a model for the study of the reticular reflex my
ISSN:0885-3185
DOI:10.1002/mds.870080105
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
5. |
Time course of distant effects of local injections of botulinum toxin |
|
Movement Disorders,
Volume 8,
Issue 1,
1993,
Page 33-37
C. G. Garner,
A. Straube,
T. N. Witt,
T. Gasser,
W. H. Oertel,
Preview
|
PDF (398KB)
|
|
摘要:
AbstractBotulinum toxin A (btx) is used to treat focal dystonias. From accidental intoxications it is known that btx can cause generalized pathologic single‐fiber electromyography (SFEMG) findings. We monitored the onset and course of these disturbances in eight patients who received a small dose of btx (2–22 ng) for therapy of focal dystonias in the head/neck region for the first time via repeated SFEMG investigations at days 0, 3, 6, 9, 12, 28, and 56. Recordings were performed in the extensor digitoum brevis muscle, and in two patients additionally in the tibialis anterior muscle. In six of these patients we found an increase of jitter and blocking. The onset of these changes was in the range of 3–13 days after injection. Fiber density showed a tendency to increase. There was no correlation between SFEMG findings and the dose of injected btx. Possible mechanisms for these observations may be either a very efficient local uptake and retrograde axonal transport via the spinal motor neurons or a systemic distribution via the blood circul
ISSN:0885-3185
DOI:10.1002/mds.870080106
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
6. |
Quantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin |
|
Movement Disorders,
Volume 8,
Issue 1,
1993,
Page 38-42
Dennis Dykstra,
Corine Ellingham,
Albert Belfie,
Tanya Baxter,
Myoung Lee,
Ann Voelker,
Preview
|
PDF (759KB)
|
|
摘要:
AbstractImprovement in cervical range of motion in patients with spasmodic torticollis by botulinum A toxin injection is difficult to objectively measure. Recently, a three‐dimensional cervical range of motion system (EMROM) that measures primary as well as secondary cervical angles has been developed. This system uses an electromagnetic tracking system for data collection and a personal computer for analysis and graphic display of the data. We have tested the EMROM system and, from our results, believe that it can be used clinically to objectively and accurately measure cervical range of motion in patients who have spasmodic torticollis and who receive botulinum toxin injection
ISSN:0885-3185
DOI:10.1002/mds.870080107
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
7. |
Inefficacy of propranolol in attenuation of drug‐induced parkinsonian tremor |
|
Movement Disorders,
Volume 8,
Issue 1,
1993,
Page 43-46
W. Steven Metzer,
Stephen R. Paige,
Joseph E. O. Newton,
Preview
|
PDF (346KB)
|
|
摘要:
AbstractWe investigated the tremolytic effect of long‐acting propranolol (propranolol‐LA) in six subjects with drug‐induced parkinsonism (DIP), using a double‐blind, placebo‐controlled, crossover experimental design. Subjects received propranolol‐LA for 2 weeks and placebo for 2 weeks, with no change in neuroleptic treatment. Tremor frequency and amplitude were objectively quantified at the end of each 2‐week period by computerized tremorgram recording. There were no significant differences in attenuation of DIP tremor by propranolol‐ LA and placebo. Previous investigations reported in the literature have found propranolol to attenuate the tremor of idiopathic parkinsonism (IPD). It is expected that DIP and IPD tremor would respond similarly to propranolol if a solely peripheral or spinal cord tremolytic action were operative. A possible differential attenuation of IPD tremor and DIP tremor provides support for the concept of a higher central tremolytic mechanism of β‐adrenergic recep
ISSN:0885-3185
DOI:10.1002/mds.870080108
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
8. |
Milacemide therapy for Parkinson's disease |
|
Movement Disorders,
Volume 8,
Issue 1,
1993,
Page 47-50
M. E. Giuffra,
V. H. Sethy,
T. L. Davis,
M. M. Mouradian,
T. N. Chase,
Preview
|
PDF (302KB)
|
|
摘要:
AbstractThe clinical effects of central glutamatergic stimulation by the glycine prodrug milacemide were studied in six patients with Parkinson's disease under double‐blind, placebo‐controlled conditions. When administered as monotherapy at a single oral dose of 1,200 mg, the drug increased overall parkinsonian severity transiently, mostly due to an effect on rigidity. Milacemide did not, however, alter levodopa‐induced dyskinesias. These results support the view that drugs acting on the glutamatergic system can influence motor function in patients with extrapyramidal movement disorders and that pharmaceutical agents that selectively block certain subtypes of glutamate receptors may ameliorate parkinsonian sym
ISSN:0885-3185
DOI:10.1002/mds.870080109
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
9. |
Neuropsychological correlates of brain atrophy in Parkinson's disease: A CT‐scan study |
|
Movement Disorders,
Volume 8,
Issue 1,
1993,
Page 51-55
Sergio E. Starkstein,
Ramón Leiguarda,
Preview
|
PDF (459KB)
|
|
摘要:
AbstractWe examined the presence of cortical or subcortical brain atrophy (as shown by CT scans) in patients with Parkinson's disease (PD) and assessed whether there were significant correlations between CT measurements and the presence of cognitive deficits. There were three main findings. First, patients with bilateral symptoms of PD showed more severe cortical and subcortical atrophy than age‐matched normal controls. Second, the presence of unilateral symptoms of PD was significantly associated with contralateral brain atrophy only in patients with right hemi‐PD. Third, there was a significant correlation between neuropsychological deficits and atrophy in specific brain ar
ISSN:0885-3185
DOI:10.1002/mds.870080110
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
10. |
Single‐doseL‐dopa response in early parkinson's disease: Measurements with optoelectronic recording technique |
|
Movement Disorders,
Volume 8,
Issue 1,
1993,
Page 56-62
Bo Johnels,
Páll E. Ingvarsson,
Björn Holmberg,
Michael Matousek,
Göran Steg,
Preview
|
PDF (535KB)
|
|
摘要:
AbstractTwenty‐five patients with suspected Parkinson's disease were submitted to optoelectronic movement analysis with the Posturo‐ Locomotor‐Manual (PLM) test before and 60 min after a single dose ofL‐Dopa. They were then examined clinically for diagnosis. Two patients were excluded due toL‐Dopa intolerance. Seventeen of the remaining patients were classified as having Parkinson's disease. The movement time (MT) in the PLM test was increased for all these patients, and they improved their performance afterL‐Dopa. The degree of improvement was roughly proportional to the pretreatment augmentation of MT in comparison to healthy subjects of the same age. The PLM phase analysis showed a specific disability profile for each individual. Six patients were given diagnoses other than PD. Some improvement was found in one patient with suspected olivopontocerebellar atrophy and one patient with multiple brain injury. Two patients with progressive supranclear palsy, one with suspected striatonigral degeneration, and one with functional disturbance deteriorated afterL‐Dopa. In conclusion, truly objective and fully reproducible evaluation of the motor performance before and after a singleL‐Dopa dose is easily accomplished with computer‐assisted modern optoelectronic recording equipment. The technique is a valuable tool for the quantitative measurement of treatment effects and contributes to the diffe
ISSN:0885-3185
DOI:10.1002/mds.870080111
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
|